Poseida Therapeutics, Inc.

Q1 2021 13F Holders

Symbol
PSTX
CUSIP
73730P108
Type
Equity
Class
COM
Num filings
65
Total reported value, excl. options
$284 M
Manager Report Date Value ($000) Shares Option Type